Vivanza Biosciences consolidated net profit declines 44.90% in the June 2024 quarter
Net profit of Vivanza Biosciences declined 44.90% to Rs 0.27 crore in the quarter ended June 2024 as against Rs 0.49 crore during the previous quarter ended June 2023. Sales declined 73.56% to Rs 2.44 crore in the quarter ended June 2024 as against Rs 9.23 crore during the previous quarter ended June 2023.
Particulars | Quarter Ended | ||
Jun. 2024 | Jun. 2023 | % Var. | |
Sales | 2.44 | 9.23 | -74 |
OPM % | 14.75 | 6.50 | - |
PBDT | 0.27 | 0.49 | -45 |
PBT | 0.27 | 0.49 | -45 |
NP | 0.27 | 0.49 | -45 |
How to Invest in Gold ETF?
6 mins read . Nov 27, 2024
List of Miniratna Companies in India 2024
8 mins read . Nov 26, 2024
Consolidated Fund of India - Explained
6 mins read . Nov 26, 2024
Explore our products
₹0 Brokerage *
Open Demat Account